Medicare Enrolled
Dr. Vigen Khojayan, M.D.
Family Medicine · Glendale, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khojayan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khojayan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khojayan
Dr. Vigen Khojayan is a family medicine specialist in Glendale, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Khojayan performed 7,866 Medicare services across 3,072 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khojayan received a total of $16,963 from 61 pharmaceutical and/or device companies across 708 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khojayan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 2% volume in CA
$16,963 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,866
Medicare services
Top 2% in CA for family medicine
3,072
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~437 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,934 | $46 | $60 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
1,783 | $77 | $100 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,053 | $66 | $140 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
672 | $77 | $100 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
306 | $99 | $150 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
240 | $97 | $200 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
229 | $108 | $250 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
208 | $3 | $10 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
200 | $235 | $300 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
183 | $8 | $10 |
| Home health agency supervision, complex multidisciplinary care Supervision by a physician or allowed practitioner for a patient receiving Medicare-covered services from a participating home health agency. This involves complex and multidisciplinary care modalities, with the patient not present during the supervision. |
177 | $79 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
170 | $109 | $177 |
| Annual depression screening | 121 | $21 | $50 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
91 | $41 | $80 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
85 | $34 | $70 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
83 | $13 | $35 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
80 | $140 | $200 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
58 | $110 | $170 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 58 | $236 | $350 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
55 | $12 | $35 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
47 | $113 | $150 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
22 | $154 | $250 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
11 | $179 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,963
Total received (2018-2024)
Avg $2,423/year across 7 years
Top 2% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
708
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,713 (92.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,250 (7.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,512
2023
$2,223
2022
$1,958
2021
$3,807
2020
$2,304
2019
$2,421
2018
$1,739
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$294
ABBVIE INC.
$264
Ardelyx, Inc.
$225
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$204
Sumitomo Pharma America, Inc.
$199
Boston Scientific Corporation
$136
AstraZeneca Pharmaceuticals LP
$128
Boehringer Ingelheim Pharmaceuticals, Inc.
$121
SHIELD THERAPEUTICS INC
$105
Novo Nordisk Inc
$102
Lundbeck LLC
$96
Almatica Pharma LLC
$81
Bayer Healthcare Pharmaceuticals Inc.
$73
GlaxoSmithKline, LLC.
$72
Phathom Pharmaceuticals, Inc.
$58
Novartis Pharmaceuticals Corporation
$53
Esperion Therapeutics, Inc.
$52
VIVUS LLC
$46
Lilly USA, LLC
$44
SCILEX PHARMACEUTICALS INC.
$40
Kowa Pharmaceuticals America, Inc.
$30
Vanda Pharmaceuticals Inc.
$25
IRONWOOD PHARMACEUTICALS, INC
$25
IDORSIA PHARMACEUTICALS US INC
$21
Xeris Pharmaceuticals, Inc.
$18
Top 3 companies account for 31.1% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,526
AstraZeneca Pharmaceuticals LP
$1,395
Amgen Inc.
$1,269
Biohaven Pharmaceuticals, Inc.
$1,250
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,211
GlaxoSmithKline, LLC.
$973
ABBVIE INC.
$837
Novo Nordisk Inc
$651
Amarin Pharma Inc.
$545
Lilly USA, LLC
$505
AbbVie Inc.
$458
Merck Sharp & Dohme Corporation
$418
PFIZER INC.
$382
Boston Scientific Corporation
$358
Ironwood Pharmaceuticals, Inc
$296
Sumitomo Pharma America, Inc.
$280
Astellas Pharma US Inc
$261
Allergan, Inc.
$245
Takeda Pharmaceuticals U.S.A., Inc.
$232
Ardelyx, Inc.
$225
Bayer HealthCare Pharmaceuticals Inc.
$220
Novartis Pharmaceuticals Corporation
$217
AbbVie, Inc.
$215
Merck Sharp & Dohme LLC
$213
Vanda Pharmaceuticals Inc.
$190
Esperion Therapeutics, Inc.
$161
Bayer Healthcare Pharmaceuticals Inc.
$160
Almatica Pharma LLC
$158
Allergan Inc.
$156
Lundbeck LLC
$149
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$123
E.R. Squibb & Sons, L.L.C.
$109
SHIELD THERAPEUTICS INC
$105
Sunovion Pharmaceuticals Inc.
$103
SANOFI-AVENTIS U.S. LLC
$102
Gilead Sciences, Inc.
$91
Horizon Therapeutics plc
$91
IDORSIA PHARMACEUTICALS US INC
$84
VIVUS LLC
$81
RedHill Biopharma Inc.
$75
Abbott Laboratories
$70
Avanir Pharmaceuticals, Inc.
$70
IRONWOOD PHARMACEUTICALS, INC
$69
Kowa Pharmaceuticals America, Inc.
$68
Nestle HealthCare Nutrition Inc.
$62
Xeris Pharmaceuticals, Inc.
$58
Phathom Pharmaceuticals, Inc.
$58
Mylan Specialty L.P.
$46
SCILEX PHARMACEUTICALS INC.
$40
Synergy Pharmaceuticals Inc
$39
West-Ward Pharmaceuticals
$36
Janssen Pharmaceuticals, Inc
$33
GENZYME CORPORATION
$31
Biohaven Pharmaceutical Holding Company Ltd.
$29
PORTOLA PHARMACEUTICALS, INC.
$24
ARBOR PHARMACEUTICALS, INC.
$22
Arbor Pharmaceuticals, Inc.
$21
Eisai Inc.
$20
ACADIA Pharmaceuticals Inc
$18
Medicure Pharma Inc.
$16
Purdue Pharma L.P.
$13
Top 3 companies account for 24.7% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · APRISO · AVYCAZ · Aimovig · Amitiza · BASAGLAR · BELSOMRA · BREO ELLIPTA · BREZTRI · BRILINTA · BYDUREON · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CREON · Creon · DALVANCE · DUPIXENT · DUZALLO · Dayvigo · ELIQUIS · EMBLEM MRI S-ICD · EMGALITY · ENTRESTO · EVENITY · Edarbi · FANAPT · FARXIGA · FLECTOR · FreeStyle Libre 2 · GEMTESA · GENERAL BPH · GENERAL - PAIN MANAGEMENT · GVOKE HYPOPEN · HETLIOZ · HUMALOG · IBSRELA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · LOKELMA · LOREEV XR · LYRICA · LifeVest · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Mitigare · Motegrity · Movantik · NEXLETOL · NUEDEXTA · NUPLAZID · NURTEC ODT · Otezla · Ozempic · PANCREAZE · PENNSAID · QULIPTA · QUVIVIQ · RAYOS · RELISTOR · RELISTOR ORAL · REXULTI · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · SPRAVATO · STEGLATRO · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · TEFLARO · TEZSPIRE · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Tresiba · Trintellix · Trulance · UBRELVY · VERQUVO · VIBERZI · VIIBRYD · VOQUEZNA · VRAYLAR · Vascepa · Veklury · Victoza · XIFAXAN · Yupelri · ZENPEP · ZORYVE · ZTLido · ZYPITAMAG (pitavastatin)
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
3,171
Per 100K population
32.2
County median income
$87,760
Nearest hospital
GLENDALE MEM HOSPITAL & HLTH CENTER
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khojayan is a clinical cardiology specialist, with above-average Medicare volume (top 2% in CA), with low-engagement industry engagement in the top 2% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khojayan experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Khojayan performed 1,934 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khojayan receive payments from pharmaceutical companies?
Yes. Dr. Khojayan received a total of $16,963 from 61 companies across 708 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khojayan's costs compare to other family medicine physicians in Glendale?
Dr. Khojayan's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khojayan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Glendale
Browse family medicine physicians in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology